USPTO 2015–2025 USPTO PatentsView US Corporation

KP Medcure, Inc.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2017–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, KP ranks #24,670 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,670
of 49,997 US assignees by volume
22nd percentile
by Innovation Score (27.0/100)
20.4
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24670 · US Corporation #24,670 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,670/49,997
  • PHOTO-FINISH Korea Resources
  • CPC-NARROW A61B · 3 areas
  • INNOV-THIN 27.0/100
  • CLAIMS-DENSE 20.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Korea Resources Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How KP’s 27.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around KP

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows KP's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for KP?

Each dot is one of KP’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). KP’s own 20.4 claims/patent is ABOVE the 6.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

KP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 0510152025 Granted patents (volume) Avg claims / patent Korea Resources Corporation - 11, 6.82Korea ResourcesKorea Zinc Co., Ltd. - 11, 15.55Korea ZincKorean Broadcasting System - 11, 5.64Korean Broadcasti…Koyo Machine Industries Co., Ltd. - 11, 5.82Koyo Machine Indu…Kriwan Industrie-elektronik GMBH - 11, 14.73Kriwan Industrie-…Kverneland Group Operations Norway AS - 11, 9.55Kverneland Group…Kwai Inc. - 11, 18.27KwaiKYB Motorcycle Suspension Co., Ltd. - 11, 5.45KYB Motorcycle Su…KP Medcure, Inc. - 11, 20.45KP Medcure
KP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where KP's grants concentrate

KP Medcure, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (4 grants) versus a trough of 3 in 2018. By volume, KP sits between Korea Resources Corporation and KYB Motorcycle Suspension Co., Ltd..

Who files at KP's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows KP holds 11 patents at rank #24,643, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near KP

By rank, the assignees closest to #24,643 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in KP's primary technology class.

KP's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2.533.544.5 201720182019 4
USPTO utility patent grants by year · 2017–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
KP Medcure, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 4 36.4%
2018 3 27.3%
2019 4 36.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

KP Medcure, Inc.'s patent record in context - here's where to go next.

  • KP Medcure, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #24,670 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare KP Medcure, Inc. against Korea Resources Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.